Abnormal widening of cortical sulci as seen in posttherapeutic cranial computed tomography (CCT) of 64 children in complete continuous remission (CCR) ofacute lymphoblastic leucemia (ALL)/non Hodgkin's lymphoma (NHL) was related to patient data and neurological complications during the application of West Berlin treatment protocol. Age and neurological/neurodevelopmental findings of the patients at diagnosis oftheir disease positively and significantly correlated with CCT abnormalities. Abnormal pre-and intratherapeutic electroencephalographic (EEG) recordings, the development of a severe polyneuropathy syndrome and/or a considerable loss of weight during treatment were frequently associated with an abnormal widening of cortical sulci. Occurrence of transient early encephalopathy syndrome, development of radiation induced blood brain barrier disturbance and somnolence syndrome were not correlated with these CCT changes. Possible explanations of these abnormalities are discussed.
Introduction
The survival rate of children sufTering from malignant diseases, particularly acute Iymphoblastic leukemia (ALL) and non Hodgkin's lymphoma (NHL) has been increased dramatically during the last decade. This is mainly due to an intensification of therapy including polychemotherapy and radiotherapy of the CNS. The quality of survival is a major subject of research at present~the majority of neurological disturbances observed during treatment are reversible. The biological nature of neurotoxic efTects of treatment and their relevance have to be studied in order to avoid possible permanent cerebral damage.
In a previous survey on efTects of antileukemic treatment we described possible neurological complications during application of the West Berlin protocols (llane.feld and Riehm 1980). In this combined prospectivc and rctrospective study we have been analysing the influence of age, developmental and neurological status and electroenccphalographic findings at diagnosis and occurrence of intratherapeutic complications ( Fig. 1 ) on posttherapeutic cranial computed tomography (CCT) findings. Since neurohistological studies of healthy survivors are lacking CCT remains the only crude method to examine the brain morphologically.
Patients and methods
The same 64 patients as in part I of this study were analysed. All were in continuous complete remission (CCR) at the time ofCCT examination after the end oftherapy ofacute lymphoblastic leukemia (ALL) or non HodXkin's lymphoma (NHL). The following data and neurological complications were selected for analysis: age at diagnosis of the disease; any pretherapeutic neurological/neurodevelopmental abnormality; presence of pretherapeutic clectroencephalographic (EEG) abnormalities~presence of EEG abnormalities during therapy; development of a polyneuropathy syndrome; development ofblood brain barrier disturbance during central nervous system (CNS) prophylaxis; occurrence of somnolence syndrome (SS, apathy syndrome); body weight loss in relation to the stature ofthe patients during antileukemic treatment.
Standardized EEG recordings were analysed. Intratherapeutic EEGs were recorded immediately after the end of phase I of protocol 1 (see part I, Fig. I ). In 18 patients no pretherapeutic and in 40 cases no intratherapeutic EEG recordings were available for technical reasons.
Polyneuropathy symptoms were classified as folIows: grade 0: no sym ptoms; grade I: loss of reflexes, weakness and muscular pain; grade 2: areflexia and sensory loss and troublesome complaints such as the patients bcing bound to their beds or walking only with additional help.
Transient early encephalopathy syndrome consists of fatigue, irritability and depression up to mutism~sometimes accompanied by papilledema of maximal I to 2 diopters during the third to fifth week of protocol I. A blood brain barrier disturbance (BBBD) developing during the cranial radiation therapy (CRT) was measured in 17 of our patients by determining the alpha 2 macroglobulin concentration in the CSF using the electroimmunoassay according to LaurelJ (1972) . The CSF was collected during lumbar punctures performed for diagnostic and therapeutic purposes.
Somnolence syndrome (SS, also called apathy syndrome or late transient encephalopathy syndrome) occurring from the sixth to the eightth week after the end of cranial radiation therapy (CRT) was graded as slight (1) or severe (2). Children with grade 2 SS were drowsy for several days and spent most ofthis time in bed.
Weight by length/stature of the patients was used for description ofnutritional state during therapy. This parameters were compared with the National Centre of Health Statistic Growth Charts (1976) and graded as 0 if the childrens' rate was normal throughout their treatment, as I if the weight was between the third and tenth percentile and graded as 2 if it reached values below the third percentile.
All these data were correlated with the respective CCT findings after the end of therapy (see part 1). In 27 % these consisted of abnormal widening of cortical sulci.
Results
Age and CCT: Children who were older than 10 years at diagnosis showed more abnormal CCT findings than children younger than 3 years of age (p = 0.029, Table I A). Similar results were obtained by excluding patients younger than 2 years at diagnosis who received a reduced CRT dose during CNS prophylaxis (p = 0.06, not shown in Table I ).
Pretherapeutic neurological abnormality and CCT: Patients who had demonstrated neurological abnormalities before therapy showed more CCT changes posttherapeutically than patients with anormal development and normal neurological status at diagnosis (p = 0.004, Table I B) . A summary of these neurological abnonnalities is given in Table 11 . The following case report stresses these findings:
St. Am. was born in April 1964 following anormal pregnancy. Early motor development was delayed. He was able to walk at the age of 20 months. He started school at the age of 6 years and was then rated of normal intelligence by a psychologist. During the following years both teachers and parents noticed increasing problems of gait, coordination, fine motor movements, articulation as weIl as behavioural disturbances. He changed from right to left handedness. When first seen by us we were able to confirme these symptoms and a preliminary diagnosis ofcerebral palsy or a mildly progressive CNS disorder of unknown origin was made. A CCT performed 1976 was normal, as were nerve conduction studies. In September 1977, aged 13 years, he was diagnosed as suffering from high risk type of ALL (without CNS involvement). Treatment according the West Berlin protocols was started lasting until November 1979. Within 2 months oftreatment a dramatic deterioration ofmotor function (mainly due to a severe Vincristin polyneuropathy) occurred and the boy had to use a wheelchair. There was also a mild degree of dementia his IQ now being in the range of 70. The patient now aged 18 years, lives in a special institution for physically handicaped adolescents. He is in CeR and his neurological symptoms and mental functions show no further progression since the cessation of therapy. His CCT revealed a marked widening ofcortical sulci.
Pretherapeutic EEG findings and CCT: Pathological EEG findings consisted ofa slowing ofbackground frequency without hypersynchronous activity. There seemed to be a slight tendency that a pathological pretherapeutic EEG coincidcd more frequently with an abnormal CCT posttherapeutically (p = 0.093), although this correlation did not reach a signiticant level (Table I-C) .
Occurrence of the transient early encephalopathy syndrome and posttherapeutic CCT findings did not corrclatc ( Table I-D) .
Polyneuropathy syndrome and CCT: Although thc pcrccntage of abnormal posttherapeutic CCT fi nding'i incrcascd ac- cording to the severity of polyneuropathy symptoms the differences did not reach a significant level (Table I-E). EEG during therapy and CCT: At this time slowing of background activity in EEG did not show a significant correlation to the posttherapeutic CCT findings (Table I-F) . Numbers were too small for statistical analysis. Blood brain barrier disturbance and CCT: In 13 patients the alpha 2 macroglobulin CSF concentration exceeded at least twice the normal range indicating a BBBD. In this small number of patients no correlation between occurrence of BBBD and abnormal posttherapeutie CCT could be detected (Table I-G) .
Somnolence syndrome and CCT: Although the pereentage of abnormal CCT inereased after the oceurrence of a severe somnolence syndrome, the eorrelation did not areach a significant level (Table I 
-H).
Weight/stature by lenght and CCT: No positive correlation could be found between this parameter and the posttherapeutic CCT findings (Table I-I).
Discussion
The purpose of this study was to analyse possible relations of individual neurological reactions to antileukemic treatment and eertain patient data in respect to morphological brain alterations as seen in posttherapeutic CCT (widening of cortical sulci).
Widening of cortical sulei characterizes the aged brain and our findings support speculations whether these changes can be related to an accelerated aging proeess (Wisniewski and Terry 1973). Since no neurohistological studies of clinically healthy patients after treatment of ALL/NHL exist, we explored whether known pathogenic mechanisms of these neurological symptoms and certain patient data contribute to the CCT abnormalities.
The higher ineidence of widening of cortical sulci in older children was surprising because earlier publications reported a higher vulnerability of the younger group to neurotoxic antileukemic treatment, especially to the CNS prophylaxis
(Cros/ey et al 1978).
This result may be related to:
I.) plasticity of skull growth in younger children, since the increase ofbrain volume determines this growth. Cerebral damage due to the antileukemic treatment could lead to a reduction ofbrain volume and subsequently to a smaller skull without visible widening of the sulci. Skull circumference studies were not done in our patients. In an older child skull growth is nearly completed, a reduction ofbrain volume would lead to complementary expansion ofCSF volume.
2.) a decreasing capacity to compensate neurotoxic effects ofantileukemic drugs in older children. This includes the possibility of an inereasing vulnerability of CNS in older children. From erude animal experiments (surgical ablation of brain lobes or disruption of neuronal connections in certain areas ofCNS) it is known that recovery ofneuronal structures and functions are always greater in earlier rather than in later stages of development and it virtually ceases after development of CNS has been completed (Jacobson 1978, Ordy et al 1973, Kerr 1975) . One might speculate that neurotoxic effects of antileukemic drugs are better compensated by the repair mechanisms ofimmature CNS than ofmature CNS.
Stephani et al Price et al (1975) reported that age at time ofirradiation did not influence the incidence of severe leucoencephalopathy. On the contrary Cros/ey et al (1978) reported of a group of 29 patients with ALL/NHL in which cerebral atrophy was more frequent in younger patients. In this post rnortern study cortical atrophy was microscopically characterized by an irregular neuronalloss in all six layers. A statistical relationship between the degree of atrophy and intrathccal MTX alone or in combination with radiation therapy was reported. It is however difficult to relate these post mortem findings in children who had received a different antileukelnic treatment and died of their leukemia with the clinical and CCT data found in our patients in CCR.
The incidence ofabnormal CCT was significantly higher in children with some pretherapeutic neurological disturbance.
From other publications (Bergstroem and Bille 1978) it is
known that psychomotor developmental and other neurological disturbances in children can be accompanied by abnormal CCT findings. The possible existence of a pretherapeutic CCT abnormality in some of our patients can therefore not be excluded.
But it is also possible that an already uabnornlal" brain becomes macroscopically altered during the ALL/NHL treatment indicating a genetic and/or acquired vulnerability of brain structures to the therapeutics as illustratcd in the case described. The neurological and develöpmental status of a patient prior to the disease and treatment is in our experience the most decisive factor in relation to his neurological and mental outcome ifno acute complications occur.
Statistically there is a tendency to increased abnormal posttherapeutic CCT findings in children with pretherapeutic EEG abnormalities. Pathological slowing of EEG is largely unspecific in respect to its origine. It could be a symptom of CNS leukemia (Fichsel et al 1972) or of the poor state of health of the patients at diagnosis (Korinthenberg et al 1979 , Korinthenberg et al 1980 . If one suspects a functional disturbance of cortical neuronal tissue by direct infiltration of blast cells or by reduced vascular blood flow, this might also result in a morphological damage to these neurons (Price 1979) .
Alternatively the increasing percentage of abnormal CCT after pathological pretherapeutic EEG may reflect the ill defined vulnerability of CNS prior to therapy. Mahoney et al (1981) described significant correlations to the development of CNS complications due to CNS therapy, e.g. the somnolence syndrome, if therapy followed severe pretherapeutic slowing of EEG activity in all brain areas. In our opinion the EEG changes described do not allow conclusivc evidence regarding CNS vulnerability to further therapy or to hidden CNS leukemia.
The percentage of abnormal CCT increases \vith the dcvclopment of a severe polyneuropathy syndrome during treatment. Like others (Gröbe and Pa/rn 1972) we ft)und a highly significant correlation between the polyneuropathy syndrome due to Vincristin and the slowing ofEEG activity at the end 01' phase 1 ofthe West Berlin protocolls (Ha1le.fi!ld et al in prcp).
Vincristin and Asparaginase are the main neurotoxic agents used in phase 1. The efTeet of Vinca Alcaloids s,~ems to hc 10-cated at (axonal) microtubuli mainly in thc pt~ripheral ner-den mittels zerebraler Computertomographie (CT) untersucht. Die gefundenen Erweiterungen des SubarachnoidaJraumes wurden bei DiagnosesteIlung korreliert zum Alter, zu entwicklungsneurologischen Vorbefunden und neurologischen Befunden, zu EEG-Veränderungen vor und während der Therapie, zur Entwicklung eines PolyneuropathieSyndromes, zum Gewichtsverlust, zur Entwicklung einer Blut-Liquor-Schranken-Störung während der Therapie sowie zum Somnolenz-Syndrom naeh der Schädelbestrahlung.
Alter und neurologische Vorbefunde korrelierten signifikant, EEG-Veränderungen, Polyneuropathie-Syndrom und Gewichtsverlust nur tendenziell und Blut-Liquor-SchrankenStörung und Somnolenz-Syndrom nicht mit den CTVeränderungen. Die mögliche Bedeutung der untersuchten Parameter fur das ZNS wird diskutiert.
vous system but probably also in central neurons. Our findings give strong supportance as to both peripheral and central nervous system involvement.
One might speculate that central Vincristin neurotoxicity is not totally reversible but may cause structural (e.g. axonal) break down leading to permanent reduction of the brain volume.
The correlation between polyneuropathy or intratherapeutic EEG and CCT did not reach a significant level due to the small number of patients. The increasing percentage of abnormal CCT after Vincristin related complications though gives some substance to this speculation.
The early transient encephalopathy syndrome is believed to arise as a eonsequence of eorticosteroid withdrawal and concomitant onset fo CRT (Han(~/eld and Riehm 1980). One effeet of steroid medication seems to be a fl uid imbalance, leading to a reversible widening of CSF spaees (Mackoa'a et al 1980, Bayer 1980 ). This syndrome does not influence posttherapeutie CCTs.
Ouring CNS prophylaxis, changes in the barrier function of the blood brain barrier occur and can be related to CRT and MTX i.th.~alpha 2 macroglobulin CSF concentration has been proven to be a sensitive parameter in estimation of this disturbance (Wen~el et al 1979 , Ratinl( et al 1978 . This increasing exposure ofthe brain to the contents ofblood did not afTect the CCT findings significantly. There is however indication that single CRT dose was positively correlated with development of BBBD (Rating et al in prep.). A high single CRT dose seems therefore important in respect to the presence of wide cortical sulci as weil as the development ofBBBD.
(~h 'ien et al (1980) stressed the importance of somnolence syndrome for longterm neurological sequelae after cranial irradiation. Our findings suggest that this syndrome is more frequently (not significantly) correlated with the reported CCT abnormalities. It is believed that a disturbance of metabolism of myelin due to ionizing radiation is the cause of this syndrome. This explanation seems unlikely since disorders of consciousness in children reflect probably a disturbance of neuronal metabolism rather than the postulated disturbance ofmyelin (f'reeman et al 1973).
It is weil known from previous studies (Nussbaum et al 1980) that in cachectic patients intraeranial CSF spaces widen reversibly. There is a slight non significant increase of abnormal CCT findings in patients passing aperiod with extensive weight loss. It remains an open question whether this is specific due to certain vitamin deficiencies or reflexes merely the general undemutrition ofthese patients.
Age, pretherapeutic neurological/neurodevelopmental abnormalities correlate with posttherapeutie CCT findings at a significant level. Pre-and intratherapeutic EEG abnormalities, the degree of polyneuropathy and weight loss during therapy seem to eontribute to these CCT findings to a lesser extent. We are not yet able to define the clinical relevance of the described CCT findings for the individual patient. The study of the neurological and mental status of these ehildren in CCR will hopefully answer this vcry important question.
Zusammenfassung
64 Kinder in kompletter kontinuierlicher Erstremission nach dem Ende der Dauertherapie einer akuten Iymphoblastischen Leukämie bzw. eines Non Hodl(kin-Lymphoms wur-
